ReviewInternal medicine (Tokyo, Japan)2019
Sclerosing Angiomatoid Nodular Transformation of the Spleen: Lessons from a Rare Case and Review of the Literature.
Review in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 32 citations in OpenAlex.
- Avoiding splenectomy in splenic sclerosing angiomatoid nodular transformation through endoscopic ultrasound-guided tissue acquisition: a 36-month follow-up case report.Clinical journal of gastroenterology · 2026Article
- Sclerosing Angiomatoid Nodular Transformation With Characteristic Imaging Findings: A Report of Three Cases Treated by Laparoscopic Splenectomy.Clinical case reports · 2025Article
- Article
- Sclerosing Angiomatoid Nodular Transformation of the Spleen: Multimodality Imaging Features.Cureus · 2025Article
- Case Report: Sclerosing angiomatoid nodular transformation of the spleen: surgery or conservative treatment?Frontiers in immunology · 2025Article
- Transumbilical single-site laparoscopic resection of splenic papillary angioendothelioma in a pediatric patient: a rare case report and review of literature.Frontiers in oncology · 2025Article
- Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a case report.Oxford medical case reports · 2024Article
- Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Report of Rare Case and Literature Review.Cureus · 2023Article
- Sclerosing angiomatoid nodular transformation of the spleen: multimodality imaging features and literature review.BMC medical imaging · 2023Review
- Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Diagnostic Conundrum.Journal of the Belgian Society of Radiology · 2022Article
- Sclerosing angiomatoid nodular transformation of the spleen: a case report.BMJ case reports · 2021Article
- Sclerosing angiomatoid nodular transformation of the spleen: A case report and literature review.World journal of clinical cases · 2021Article
- Sclerosing angiomatoid nodular transformation presenting with thrombocytopenia after laparoscopic splenectomy - Case report and systematic review of 230 patients.Annals of medicine and surgery (2012) · 2020Article
- Sclerosing angiomatoid nodular transformation of the spleen: case report of a metastatic carcinoma-simulating disorder.Journal of surgical case reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing angiomatoid nodular transformation (SANT) of the spleen is an extremely rare benign lesion. We herein report a case of asymptomatic SANT of the spleen in a middle-aged woman with early breast carcinoma and an undiagnosed splenic mass, which was successfully treated by laparoscopic splenectomy and diagnosed postoperatively. We also review the literature on SANT to help make knowledge more accessible when clinicians encounter a splenic tumor. The present case taught us the following lesson: the presence of a splenic lesion during follow-up for malignancy is not always indicative of metastasis. Therefore, SANT should be considered in the differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.